美國白內障手術市場(2026 年)
市場調查報告書
商品編碼
2056920

美國白內障手術市場(2026 年)

2026 United States Cataract Surgeon Survey Report

出版日期: | 出版商: Market Scope, LLC | 英文 | 商品交期: 最快1-2個工作天內

價格
簡介目錄

概述

Market Scope發布的《美國白內障手術市場(2026)》報告對美國白內障手術市場的現狀和未來發展方向進行了詳細分析。該報告基於115位白內障手術醫生的回饋,這些醫生代表了來自各種臨床機構的1000多名醫生,報告深入分析了外科醫生的偏好、技術應用以及不斷變化的市場動態,提供了切實可行的見解。

本調查檢驗了診所的特徵、手術技術、產品使用、病患教育和行銷策略以及購買行為。此外,它還廣泛涵蓋了高階白內障手術的發展趨勢,包括老花眼矯正、散光矯正、增強型單焦點和景深擴展型人工水晶體(IOL)的應用、散光管理、飛秒雷射輔助白內障手術(FLACS)、手術設施的發展趨勢、患者融資以及對新興技術和設備的興趣。

此外,本報告按製造商、品牌和產品類型提供了詳細的市場佔有率分析,清楚地展現了人工人工水晶體(IOL)、faco系統、黏彈劑、術中藥物、微創白內障手術(MIGS)器械及其他關鍵白內障手術產品的競爭格局。報告中也檢驗了合併青光眼的治療模式、MIGS的應用情況以及外科醫師對未來市場趨勢的觀點。

本報告面向製造商、投資者和行業相關人員,結合外科醫生報告的數據和專家分析,全面概述了美國白內障市場的趨勢,使其成為戰略規劃、產品開發和競爭情報收集的重要資源。

目錄

這份報告不僅僅是對當前市場的簡單截面分析;它追蹤了外科醫生的偏好、購買行為和技術採用情況隨時間的變化,提供了有價值的背景信息,以識別新的機會並預測未來的變化。

本報告透過與以往版本的比較,分析了白內障手術最重要領域的發展趨勢,具體如下:

  • 診所收入、成長和轉診
  • 手術數量趨勢和醫療地點變化
  • 按製造商、型號、類別和 ASC(摘要手術中心)類型分類的 IOL 市場佔有率
  • 高階人工水晶體、老花眼矯正型人工水晶體、增強型單焦點人工水晶體、EDOF人工水晶體和散光矯正型人工水晶體的引進現狀
  • 散光管理技術與使用趨勢
  • 微創手術和飛秒雷射輔助白內障手術(FLACS)的應用
  • Facomine市場佔有率、更換週期和採購計劃
  • 一次性產品、手術包和手術耗材的使用
  • FLACS 和 MIGS 技術的當前和未來部署狀況
  • 定價、資金籌措、行銷策略以及乾眼症患者的管理。
  • 未來12個月的臨床擴展計畫與投資重點

無論您是在評估市場機會、監控競爭對手趨勢,還是製定下一個產品策略,本報告都將提供以外科醫生觀點的信息,幫助您做出更明智的決策。

簡介目錄

Description:

Market Scope’s "2026 United States Cataract Surgeon Survey Report" provides an in-depth look at the current state and future direction of the US cataract surgery market. Based on responses from 115 cataract surgeons representing more than 1,000 practitioners across a wide range of practice settings, the report delivers actionable insights into surgeon preferences, technology adoption, and evolving market dynamics.

The survey examines practice characteristics, surgical techniques, product utilization, patient education and marketing strategies, and purchasing behavior. Expanded coverage explores premium cataract surgery trends, including presbyopia-correcting, toric, enhanced monofocal, and EDOF IOL adoption, astigmatism management, femtosecond laser-assisted cataract surgery (FLACS), surgical site trends, patient financing, and interest in emerging technologies and equipment.

The report also provides detailed market share analysis by manufacturer, brand, and product category, offering a clear view of the competitive landscape across IOLs, phaco systems, viscoelastics, intraoperative pharmaceuticals, MIGS devices, and other key cataract surgery products. Additional sections examine glaucoma co-management patterns, MIGS utilization, and surgeon perspectives on future market developments.

Designed for manufacturers, investors, and industry stakeholders, this report combines surgeon-reported data with expert analysis to deliver a comprehensive view of the trends shaping the US cataract market, making it an essential resource for strategic planning, product development, and competitive intelligence.

Contents:

More than a snapshot of today's market, this report tracks how surgeon preferences, purchasing behavior, and technology adoption have evolved over time to provide valuable context for identifying emerging opportunities and anticipating future shifts.

Drawing on comparisons with prior editions, the report delivers trend analysis across the most important areas of cataract surgery, including:

  • Practice revenue, growth, and referral sources
  • Surgical volume trends and shifts in site of care
  • IOL market share by manufacturer, model, category, and ASC type
  • Adoption of premium, presbyopia-correcting, enhanced monofocal, EDOF, and toric IOLs
  • Astigmatism management techniques and utilization trends
  • Use of micro-incision surgery and femtosecond laser-assisted cataract surgery (FLACS)
  • Phaco machine market share, replacement cycles, and purchasing plans
  • Utilization of single-use products, procedure packs, and surgical consumables
  • Current and planned adoption of FLACS and MIGS technologies
  • Patient pricing, financing, marketing strategies, and dry eye management
  • Practice expansion plans and investment priorities for the next 12 months

Whether you're evaluating market opportunities, monitoring competitive dynamics, or planning your next product strategy, this report provides the surgeon-driven intelligence needed to make more informed decisions.